Join our daily newsletter At The Bell to receive exclusive market insights
- HeraMED (HMD) announces Gold Coast Hospital will trial its ‘HeraCARE’ platform as its new standard of care for Women Newborn and Children Services (WNCS)
- The trial will include up to 90 pregnancies for between six to nine months, assessing clinical useability, patient satisfaction, value for money and economic analysis
- HeraMED CEO and Co-founder David Groberman says it’s a “significant milestone” for the Israel-based company
- The hospital’s operator, Gold Coast Health, is an internationally-recognised health institution improving patient care and experience through digital transformation and innovation
- Shares in HMD last traded at 11 cents at midday AEDT
Pregnancy technology company HeraMED (HMD) has inked a memorandum of understanding (MOU) with Gold Coast Hospital to trial its ‘HeraCARE’ platform.
The hospital will trial HeraMED’s platform as its new standard of care for its Women Newborn and Children Services (WNCS).
HeraMED CEO and Co-founder David Groberman said the MoU signalled a significant win for the Israeli-based company.
“This MOU represents a significant milestone for HeraMED and an important validation of our technology and business model and is our first major win with a government establishment on the Australian East Coast,” Mr Groberman said.
“The Gold Coast Hospital is leading the way in (the) digitisation of healthcare, and we are delighted that they are planning to adopt our technology as their standard of care for remote pregnancy monitoring.”
The controlled trial will include up to 90 pregnancies for between six to nine months, assessing clinical useability, patient satisfaction, value for money and economic analysis.
If successful, and following the completion of the trial, the hospital has indicated its intention to order additional licenses.
“Having successfully completed the first stage of our transformation agenda, which was to digitally enable our health service, the focus now is to leverage new technologies to improve the quality and experience of patient care, and we expect the HeraCARE platform will deliver on these goals as our new standard of care,” Gold Coast Health Executive Director of Strategy, Transformation and Major Capital Sandip Kumar said.
The Gold Coast Hospital is making waves in setting the pace for digital transformation within the healthcare sector. Its operator, Gold Coast Health, is an internationally-recognised health institution aiming to improve patient care and experience through digital transformation and innovation.
Shares in HMD last traded at 11 cents at midday AEDT.
